PCM
ALDR

Peregrine Capital Management’s Alder Biopharmaceuticals, Inc. ALDR Stock Holding History

Peregrine Capital Management’s Portfolio ALDR Stock Details ALDR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-416,052
Closed -$8.82M – 259
2017
Q1 		$8.82M Buy
416,052
+63,643
+18% +$1.35M 0.22% 194
2016
Q4 		$7.33M Buy
352,409
+6,000
+2% +$125K 0.19% 233
2016
Q3 		$11.4M Buy
+346,409
New +$11.4M 0.3% 139